BCL6 and breast cancer: Under normal conditions, ZBTB16 acts as a transcriptional repressor that inhibits breast cancer proliferation and metastasis by upregulating ZBTB28 and antagonizing oncogenic factors such as BCL6/ZBTB27 [57].